Cardio Diagnostics Holdings Inc. announced that the Japan Patent Office has issued a patent for its AI-driven cardiovascular disease detection technology. The patent, titled "Compositions and Methods for Detecting Predisposition to Cardiovascular Disease" (Japanese Patent No. 7672192), is exclusively licensed from the University of Iowa Research Foundation. This marks a significant milestone in Cardio Diagnostics' efforts to globalize its precision cardiovascular medicine platform. The patent protects the company's innovative methods and compositions that utilize epigenetic and genetic biomarkers interpreted through advanced machine learning algorithms to detect cardiovascular disease risk and presence.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.